IQV
IQVIA Holdings Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$267.40
−1.55%Aug 21, 2026, 19:51 UTC
Iqvia Holdings Inc. stock reached a 52-week high of $260.32, reflecting a 38% gain over the past year and a 54.6% surge over the past six months.
Source:Aug 20, 2026, 07:24 UTC
BlackRock Inc. acquired a new position in IQVIA Holdings Inc., buying 14,549,693 shares valued at approximately $2.81 billion, representing about 8.84% ownership, as disclosed in a 13F filing.
Source:Jul 28, 2026, 11:11 UTC
IQVIA Holdings reported its Q2 FY2026 (April-June) financial results, with revenue up 8.7% year-over-year to $4.368 billion, operating income flat at $506 million, and diluted EPS of $1.53.
Jul 27, 2026, 04:35 UTC
IQVIA promoted Roy Rohan Richard to director of talent acquisition.
Source:Jun 11, 2026, 00:00 UTC
IQVIA Holdings Inc. issued €950 million aggregate principal amount of 4.625% senior unsecured notes due 2033, with net proceeds to refinance existing indebtedness and pay offering-related fees and expenses.
Jun 4, 2026, 14:51 UTC
IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings Inc., priced an offering of €950 million in senior notes due 2033 to refinance existing indebtedness.